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Abstract
We studied the control of dorsal raphe (DR) serotonergic
neurons by dopaminergic transmission in rat brain using
microdialysis and single unit extracellular recordings. Apo-
morphine (0.5±3.0 mg/kg s.c.) and quinpirole (0.5 mg/kg s.c.)
increased serotonin (5-HT) output in the DR and (only
apomorphine) in striatum. These effects were antagonized
by 0.3 mg/kg s.c. SCH 23390 (in DR and striatum) and
1 mg/kg s.c. raclopride (in DR). 5-HT1A receptor blockade
potentiated the 5-HT increase produced by apomorphine in
the DR. Apomorphine (50±400 mg/kg i.v.) increased the ®ring
rate of most 5-HT neurons, an effect prevented by SCH 23390
and raclopride. Quinpirole (40±160 mg/kg i.v.) also enhanced
the ®ring rate of 5-HT neurons. When applied in the DR,
neither drug increased the 5-HT output in the DR or striatum.
Likewise, micropressure injection of quinpirole (0.2±8 pmol)
failed to increase the ®ring rate of 5-HT neurons. In situ
hybridization showed that the dopamine (DA) D2 receptor
transcript was almost absent in the DR and abundant in the
substantia nigra (SN) and the periaqueductal grey matter
(PAG). Using dual probe microdialysis, the application of
tetrodotoxin or apomorphine in SN signi®cantly increased the
DR 5-HT output. Thus, the discrepancy between local and
systemic effects of dopaminergic agonists and the absence of
DA D2 receptor transcript in 5-HT neurons suggest that DA D2
receptors outside the DR control serotonergic activity.
Keywords: DA receptors, extracellular recordings, 5-hydroxy-
tryptamine release, 5-HT1A receptors, in situ hybridization,
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The serotonergic (5-hydroxytryptamine, 5-HT) and dopa-
minergic systems interact in many ways in mammalian
brain. The serotonergic transmission facilitates the release of
striatal dopamine (DA), although the receptor subtype(s)
involved remain to be fully clari®ed (Blandina et al. 1988;
Chen et al. 1991; Benloucif et al. 1993; Galloway et al.
1993; Bonhomme et al. 1995; de DeurwaerdeÁre et al. 1995;
1997, 1998). There is also anatomical and functional
evidence of an interaction between the serotonergic dorsal
raphe nucleus (DR) and the dopaminergic mesencephalic
nuclei (Azmitia and Segal 1978; Van der Kooy and Hattori
1980; Stern et al. 1981; HoÈkfelt et al. 1984; KaleÂn et al.
1988; Peyron et al. 1995). The pars reticulata of substantia
nigra (SN), containing the dendrites of nigrostriatal
dopaminergic neurons, receives a very dense serotonergic
input from the DR (Fallon and Loughlin 1995) which
modulates the activity of striatonigral GABAergic afferents
(Stanford and Lacey 1996). On the other hand, the electrical
stimulation of the SN suppressed the ®ring activity of DR
serotonergic neurons (Stern et al. 1981). At postsynaptic
level, the striatum is a major area for the convergence of
ascending dopaminergic and serotonergic inputs from the
midbrain, together with glutamatergic inputs from the
cerebral cortex and thalamic nuclei (Azmitia and Segal
1978; BjoÈrklund and Lindvall 1984; Graybiel 1990).
Serotonergic agents modify the activity of dopaminergic
cell units (Ugedo et al. 1989; Nedergaard et al. 1991;
Arborelius et al. 1993, 1994; Lejeune and Millan 1998) and
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the microinfusion of 5-HT in the ventral tegmental area
increased DA release in N. accumbens (Guan and McBride
1989). Conversely, the stimulation of dopaminergic recep-
tors by apomorphine increased the 5-HT output in the DR
and forebrain (FerreÂ et al. 1994; Matsumoto et al. 1996;
Mendlin et al. 1998) and the local application of l-DOPA in
the SN enhanced the local 5-HT output (ThorreÂ et al. 1998).
These observations suggest that dopaminergic and seroton-
ergic systems modulate each other to act in a co-operative
manner in the forebrain. However, the localization of the
DA receptors involved in the apomorphine-induced increase
in 5-HT output is not known. Mendlin et al. (1998, 1999)
blocked the striatal increase in 5-HT output induced by
behavioural activation and by the systemic apomorphine
administration with local application of the DA D2
antagonist raclopride. However, the local application of
the DA D2-like agonist quinpirole in a wide range of
concentrations did not modify the striatal 5-HT output (FerreÂ
et al. 1994; AbellaÂn et al. 2000b).
To further study the dopaminergic control of 5-HT
neurons of the DR, we have conducted the present in vivo
study using single unit extracellular recordings of 5-HT
neurons in the DR and intracerebral microdialysis in the DR
and striatum. This has been complemented by an in situ
hybridization analysis to examine the presence of cells
expressing DA D2 receptors in the DR and neighbouring
areas. The results support the proposal that DA D2-like
receptors outside the DR increase the activity of DR 5-HT
neurons. These are possibly located (among other areas) in
the SN and the periaqueductal grey matter (PAG).
Materials and methods
Animals
Male albino rats weighing 280±320 g (Iffa Credo, Lyon, France)
and 200±300 g (University of the Basque Country) were used in
microdialysis and electrophysiological experiments, respectively.
Animals were kept in a controlled environment (12-h light-dark
cycle and 22 ^ 28C). Food and water were provided ad libitum.
Animal care followed the European Union regulations (OJ of EC
L358/1 18/12/1986).
Drugs and reagents
5-HT oxalate, 8-OH-DPAT (1/±)-8-hydroxy-2-(di-N-propylamino)-
tetralin, apomorphine´HCl, quinpirole´HCl, SCH 23390 [R(1)-7-
chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benz-
azepine´HCl] tetrodotoxin (TTX), veratridine and WAY 100635
N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl)-
cyclohexanecarboxamide´3HCl were from RBI (Natick, MA,
USA). Citalopram´HBr and raclopride were kindly provided by
Lundbeck A/S (Copenhagen-Valby, Denmark) and Astra (Soder-
taÈlje, Sweden), respectively. Other materials and reagents were
from local commercial sources. Drugs were dissolved in saline and
injected s.c. (microdialysis experiments) or i.v. (single unit
recordings). Doses are expressed as free bases. Control rats
received vehicle. For the assessment of local effects in micro-
dialysis experiments, the drugs were dissolved in the perfusion ¯uid
and applied by reverse dialysis. Concentrated solutions (1 mm; pH
adjusted to 6.5±7 with NaHCO3 when necessary) were stored
frozen (2 808C) and working solutions were prepared daily by
dilution.
Surgery and microdialysis procedures
An updated description of the microdialysis procedures used can
be found in Adell and Artigas (1998). Brie¯y, anaesthetized
rats (sodium pentobarbital, 60 mg/kg i.p.) were stereotaxically
implanted with concentric microdialysis probes equipped with a
Cuprophan membrane in the DR (AP 2 7.8, L 2 3.1, DV27.5,
with an angle of 308; probe tip 1.5 mm), dorsal striatum (AP 1 0.2,
L 2 3.0, DV28.0; probe tip 4.0 mm) or the SN (AP 2 5.3,
L 1 2.4, DV28.4; probe tip 1.5 mm) (coordinates in mm from
bregma and duramater; Paxinos and Watson 1986). At 20±24 h
after surgery, probes were perfused at 0.25 mL/min with arti®cial
cerebrospinal ¯uid (125 mm NaCl, 2.5 mm KCl, 1.26 mm CaCl2
and 1.18 mm MgCl2). After a 1-h stabilization period, four
fractions were collected to obtain basal values before local or
systemic administration of drugs. Successive 20-min (5 mL)
dialysate samples were collected. Unless otherwise indicated, the
perfusion ¯uid was supplemented with 1 mm of the selective 5-HT
reuptake inhibitor citalopram. This enhanced the detectability of
5-HT in dialysate samples and enabled to measure drug effects on
5-HT release, because in absence of an uptake blocker the 5-HT
collected in brain dialysates is representative of the equilibrium
between release and reuptake (Jackson and Abercrombie 1992;
Romero et al. 1998). To avoid the enhancement of 5-HT release in
the DR induced by handling and injection procedures (Adell et al.
1997), the rats were gently manipulated before performing the
microdialysis experiments. To examine the role of dopaminergic
receptors in the DR (or SN) on the 5-HT output in striatum (or DR),
groups of rats were implanted with two probes, as described above.
Drugs (apomorphine, quinpirole or TTX) were dissolved in the
dialysis ¯uid, perfused through the probe located in the DR or SN
and their effects on local and distal 5-HT output were examined.
Control rats were perfused for the whole experiment with arti®cial
CSF but sham changes of the perfusion syringes were equally done.
At the end of the experiments, rats were killed by an overdose of
sodium pentobarbital. The placement of the dialysis probes was
examined by perfusion of Fast Green dye and visual inspection of
the probe track after cutting the brain at the appropriate levels. The
data of animals with the probes outside the structures of interest
were not included in the calculations. The concentration of 5-HT in
dialysate samples was determined by HPLC method, as described
(Adell and Artigas 1998). The composition of HPLC eluant was as
follows: 0.15 m NaH2PO4, 1.3 mm octyl sodium sulphate, 0.2 mm
EDTA (pH 2.8 adjusted with phosphoric acid) plus 27% methanol.
5-HT was separated on a 3-mm ODS 2 column (7.5 cm  0.46 cm;
Beckman, San Ramon, CA, USA) and detected amperometrically
with a Hewlett Packard 1049 detector (oxidation potential
1 0.6 V). Retention time was 3.5±4 min. The absolute detection
limit for 5-HT was 0.5±1.0 fmol/sample. Dialysate 5-HT values
were calculated by reference to standard curves run daily. In some
experiments, the samples of rats treated locally with apomorphine
in the DR were analyzed with a slight modi®cation of the above
HPLC method. Brie¯y, run time was increased to 45 min per
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sample to avoid the interferences produced by apomorphine and
other minor peaks in the HPLC trace.
Extracellular recordings of DR 5-HT neurons
The rats were anaesthetized with chloral hydrate (400 mg/kg, i.p.).
A tracheal cannula was inserted and a jugular vein catheter was
placed for additional injections of anaesthetic and other drugs. The
rats were placed in a David Kopf stereotaxic frame (DKI, Tujunga,
CA, USA) and rectal temperature was maintained at 378C by means
of an electric heating pad. After exposing the skull, a 4-mm burr
hole was drilled in the midline over the DR. The sagital sinus was
ligated, cut and re¯ected. Single unit extracellular recordings from
DR neurons were made as previously described (Wang and
Aghajanian 1982). The recording electrode was an Omegadot
single-barrel glass micropipette (List Biological Labs, Campbell,
CA, USA) ®lled with a 2% solution of Pontamine sky blue in 0.5%
sodium acetate. The impedance of the electrode (tip diameter
1±2 mm), measured in 0.9% NaCl at 135 Hz, was 2±6 mV. The
electrode was placed in the midline 1 mm anterior to lambda and
4.5±6.0 mm ventral to the exposed tissue, according to the atlas
Fig. 1 Effect of the administration of apomorphine and quinpirole on
the 5-HT output in the dorsal raphe nucleus (a, c and e) and dorsal
striatum (b, d and f ). The subcutaneous administration of apo-
morphine (Apo; 0.5, 1 and 3 mg/kg s.c.; injections marked by
arrows) increased the 5-HT output in the dorsal raphe nucleus (a)
and dorsal striatum (b). The administration of the selective DA
D2-like agonist quinpirole (Quin, 0.5 mg/kg) enhanced the 5-HT out-
put in the dorsal raphe nucleus (c) but not in dorsal striatum (d). The
increase in 5-HT output produced by 3 mg/kg apomorphine in the
dorsal raphe nucleus was potentiated by the administration of
0.3 mg/kg s.c. WAY 100635 (WAY). The administration of WAY
100635 alone increased signi®cantly the 5-HT output in the dorsal
raphe nucleus but not in dorsal striatum (note the different scale in e
and f ). Data are mean ^SE of 5±8 rats/group. Control rats (open
circles, n  5 in dorsal raphe nucleus and 6 in striatum) were
injected with saline. See text for statistical analysis.
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of Paxinos and Watson (1986). The signal from the recording
electrode was passed through a high-input impedance ampli®er,
delivered to an audiomonitor and continuously monitored on an
oscilloscope. Single neuronal spikes were discriminated in a
custom-made unit, counted in an electronic rate counter, sent to a
computer generating interspike time interval histograms and
recorded on a pen chart recorder as spikes per 10 s. In experiments
assessing the effects of i.v. administration of drugs, only one cell
per rat was recorded. DR serotonergic cells were identi®ed by their
long duration action potentials and a regular, slow (0.5±3 spikes/s)
discharge rate. We administered the selective 5-HT1A receptor
agonist 8-OH-DPAT at the end of the experiments to additionally
con®rm the serotonergic nature of the recorded cells. A 5-mA
cathodal current was passed through the recording electrode in
order to leave a blue spot at the recording site. The brains were
®xed by intracardial perfusion with 4% formalin and frozen
sections (50-mm thick) were stained with neutral red and examined
microscopically for histological veri®cation of the recording site.
Pressure microinjection into the DR
For the local administration of quinpirole, a thick-walled pipette
with a calibrated inner diameter (Blaubrand; Intramark, Houston,
TX, USA) was glued to a recording electrode, according to Akaoka
et al. (1992). The calibrated pipettes were ®lled with Dulbecco's
buffered saline solution containing (in mm): NaCl 136.9, KCl 2.7,
NaH2PO4 8.1, KH2PO4 1.5, MgCl2 0.5 and CaCl2 0.9 (pH 7.4),
with or without quinpirole. Drug ejection was performed by
applying pressure pulses (100±200 ms) with a solenoid-controlled
pneumatic device (PicospritzerTM II, General Valve Corporation;
Fair®eld, NJ, USA). The volume injected was measured by
monitoring the movement of the ¯uid in the calibrated pipette. In
each rat we checked the sensitivity of the last recorded neuron to
the i.v. administration of 8-OH-DPAT.
In situ hybridization histochemistry
Oligonucleotide probes complementary to the mRNA coding for
the rat dopamine D2 receptor (bases 1212±1245, Bunzow et al.
1988; Mengod et al. 1989), the 5-HT transporter (bases 612±659,
Blakely et al. 1991) and glutamic acid decarboxylase (GAD) (bases
1537±1590, Kobayashi et al. 1987) were used. Oligonucleotides
were labelled at the 3 0 end with terminal deoxynucleotidyltransferase
(Boehringer Mannheim, Mannheim, Germany) and [32P]a-dATP
(3000 Ci/mmol; DuPont±NEN, Boston, MA, USA) to speci®c
activities of 2±3  104 Ci/mmol. The labelled probes were puri-
®ed with Qiaquick columns (Qiagen, Valencia, CA, USA).
Tissue treatment before hybridization was essentially as
described (VilaroÂ et al. 1992). For hybridization, labelled probes
were diluted to a ®nal concentration of 2  107 cpm/mL in a
solution containing 50% formamide, 4  SSC (1  SSC: 150 mm
NaCl, 15 mm sodium citrate), 1  Denhardt's solution (0.02%
®coll, 0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin),
10% dextran sulphate, 1% sarkosyl, 20 mm phosphate buffer
pH 7.0, 250 mg/mL yeast tRNA, 500 mg/mL salmon sperm DNA.
Tissue sections (14 mm thick) were covered with 80 mL of
hybridization solution, overlaid with Nesco®lm coverslips, and
incubated overnight in humid boxes at 428C. Sections were washed
four times (45 min each) in 600 mm NaCl, 20 mm Tris-HCl
pH 7.5, 1 mm EDTA at 608C, dehydrated in graded ethanols and
dried. Hybridized sections were dipped in liquid emulsion (LM1,
Amersham) and exposed for 4 weeks for the 5-HT transporter
mRNA, 5 weeks for the GAD mRNA and 7 weeks for the
dopamine D2 receptor mRNA.
Data treatment and statistics
The concentration of 5-HT in dialysates (mean ^SE) is expressed
as fmol/fraction and represented in ®gures as percentages of
baseline (average of 3±4 predrug fractions). The statistical analysis
was performed using one-or two-way analysis of variance (anova)
for repeated measures of raw data (fmol/fraction) followed by
Tukey's test where appropriate. We analysed the effect of the
independent factor (treatment group), the repeated factor (time) and
the interaction between them. The latter assessed whether the
change in 5-HT over time differs between treatment groups (e.g.
treated versus controls). Thus, a signi®cant p-value of the treatment
or the time±treatment interaction indicates differences in the effects
of two or more treatments on 5-HT output. Averaged values of
Fig. 2 The administration of the DA D1 receptor antagonist SCH
23390 (0.3 mg/kg s.c., ®rst arrow) antagonized the increase in 5-HT
output produced by the administration of apomorphine (0.5 mg/kg
s.c., second arrow) in the dorsal raphe nucleus (a) and striatum (b).
Likewise, the DA D2 receptor antagonist raclopride (1 mg/kg s.c.,
®rst arrow) antagonized, though to a lesser extent than SCH 23390,
the effect of apomorphine in the dorsal raphe nucleus. Note that the
Y-axis scales are different in (a) and (b) due to the increase in 5-HT
output elicited by the repeated injection procedure in two experi-
mental groups in the dorsal raphe nucleus. Data are mean ^SEM
of 4±7 rats/group. See text for statistical analysis.
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post-treatment periods (100 min; fractions 6±10) have been used to
examine the effects of DA receptor antagonists on the increase in
5-HT output produced by apomorphine. In these calculations, the
data from fraction 5 (®rst post-treatment fraction) were omitted
from the calculations due to the increase in 5-HT (Adell et al. 1997)
produced by the two-injection procedure in the DR. In electro-
physiological recordings, the individual ®ring rates during baseline
and drug periods were averaged and computed using 1-min periods
and compared using paired Student's t-tests. Statistical signi®cance
has been set at the 95% con®dence level (two-tailed).
Results
Baseline 5-HT output
Baseline dialysate 5-HT concentrations in presence of 1 mm
citalopram were 35.3 ^ 1.9, 18.3 ^ 1.0 and 27.2 ^ 4.1
fmol/fraction in the DR, dorsal striatum and SN (n  104,
79 and 11, respectively). In absence of citalopram, the
corresponding values in DR and striatum were 6.5 ^ 1.0
and 2.7 ^ 0.5 fmol/fraction (n  13 and 11, respectively).
The dialysate 5-HT values in the DR were signi®cantly
greater than in the striatum in presence of citalopram
( p , 0.00001, Tukey's test post anova).
Enhancement of the 5-HT release by systemic
apomorphine and quinpirole
The administration of the non-selective DA receptor agonist
apomorphine (0.5, 1 and 3 mg/kg s.c.) resulted in a stereo-
typed behaviour (mainly snif®ng, licking and grooming) and
enhanced the 5-HT output in the DR (F15,270  6.81,
p , 0.0001 time effect; F45,270  1.69, p , 0.006 time±
dose interaction; Fig. 1a) and dorsal striatum (F3,26  3.52,
p , 0.03 dose effect; F15,390  4.12, p , 0.0001 time
effect; Fig. 1b). Where the lower dose was used, the
maximal elevation of the striatal 5-HT output occurred
soon after administration (40 min). Higher doses (1 and
3 mg/kg s.c.) elicited a more persistent elevation, with the
maximal increase occurring 2 h after administration
(Fig. 1b). In the DR, the differences in 5-HT output at the
three doses used were more conspicuous than in striatum
and maximal elevations occurred at 40±60 min post-
administration. Beyond this time point, the 5-HT output
declined rapidly at 0.5 mg/kg but remained elevated until
Fig. 3 (a and b) The perfusion of apomorphine (10, 100 and
300 mM) in the dorsal raphe nucleus of rats bearing two dialysis
probes did not alter the 5-HT output in the dorsal striatum and
reduced it in the dorsal raphe nucleus at 300 mM (®lled circles,
n  5). Control rats (open circles, n  7 in dorsal raphe nucleus,
n  5 in striatum) were perfused with arti®cial CSF throughout the
experiment. (c, d) The perfusion of quinpirole (QUIN; 10, 100 and
300 mM) in the DR of rats bearing two dialysis probes did not alter
the 5-HT output in the DR or dorsal striatum (®lled circles, n  10 in
DR; n  6 in striatum). Control rats (open circles, n  7 in DR,
n  5 in striatum) were perfused with arti®cial CSF throughout the
experiment. The lower number of rats in striatum is due to sample
lost during the HPLC analysis.
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the end of the experiment (4 h postadministration) in the rats
treated with 3 mg/kg apomorphine.
To examine whether the presence of citalopram interfered
the effects of apomorphine, a group of rats was treated with
this agent but in this case the dialysis probes were perfused
with an arti®cial CSF devoid of citalopram. The adminis-
tration of 0.5 mg/kg apomorphine (n  6) elevated sig-
ni®cantly the striatal 5-HT output with respect to controls
(maximal increase 192 ^ 20% of controls; n  5)
(F15,135  2.02, p , 0.02 time effect; F15,135  2.97,
p , 0.0004 time±dose interaction). The 5-HT output in
the DR was also increased by apomorphine (1 and 3 mg/kg)
in absence of citalopram, to a maximum of 150 ^ 16% of
baseline (F15,165  2.07, p , 0.015 time effect).
The administration of the DA D2-like receptor agonist
quinpirole (0.5 mg/kg s.c.) also increased signi®cantly the
5-HT output in the DR (F15,105  3.15, p , 0.0003;
Fig. 1c). However, it failed to induce a similar increase in
striatum (Fig. 1d). Given this difference between the effects
of apomorphine and quinpirole in striatum, we examined
whether DA D1 receptors could be involved in the 5-HT-
enhancing action of apomorphine. Groups of rats were
administered with saline or the selective DA D1 receptor
antagonist SCH 23390 (0.3 mg/kg s.c.) 20 min before
apomorphine. SCH 23390 signi®cantly attenuated the
increase in DR 5-HT output produced by 0.5 mg/kg s.c.
apomorphine. The average post-treatment values for the
saline 1 apomorphine and SCH 23390 1 apomorphine
groups were, respectively, 141 ^ 11% (n  5) and
87 ^ 13% (n  4) ( p , 0.02, Student's t-test). Pretreat-
ment with raclopride (1 mg/kg s.c., 20 min before apo-
morphine) also attenuated the apomorphine-induced
Fig. 4 (a) Integrated ®ring rate histograms showing the effect of
cumulative doses of apomorphine (50±400 mg/kg i.v.) on the activity
of one serotonergic neuron in the dorsal raphe nucleus. The sero-
tonergic nature of the units recorded (one per rat) was further tested
by cumulative injections of the selective 5-HT1A agonist 8-OH-DPAT,
which markedly suppressed the ®ring activity. (b) The previous treat-
ment with raclopride (125 mg/kg i.v. injected 4 min before apomor-
phine) or SCH 23390 (400 mg/kg i.v. injected 4 min before
apomorphine) signi®cantly prevented the increase in serotonergic
®ring rate elicited by apomorphine. The increase in ®ring rate elicited
by apomorphine corresponds to the cells excited by this drug (c and
d). Representative integrated ®ring rate histograms showing the
effect of the i.v. injection of quinpirole on the activity of identi®ed
5-HT neurons of the dorsal raphe nucleus. (c) and (d) show the
effect of cumulative doses (40±160 mg/kg i.v.) and of a single
160 mg/kg i.v. dose on the activity of two different units, respectively.
8-OH-DPAT (0.5±2 mg/kg i.v.) fully suppressed the ®ring activity. (e)
and (f ) Integrated ®ring rate histograms showing the effect of the
micropressure injection of quinpirole (arrows) on the electric activity
of 5-HT neurons of the dorsal raphe nucleus. Shown are representa-
tive examples of quinpirole-sensitive (e; cumulative dose: 0.8 pmol)
and a quinpirole-insensitive (f; cumulative dose: 4.4 pmol) 5-HT
neurons.
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increase of the 5-HT output in DR (Fig. 2), although the
antagonism exerted by this dose was less marked than that
of SCH 23390 and was only marginally signi®cant
(141 ^ 11 versus 113 ^ 3%, n  5 and 4, respectively;
p  0.06, Student's t-test). In the dorsal striatum, pretreatment
with SCH 23390 (0.3 mg/kg s.c.) 20 min before apomorphine
0.5 mg/kg also attenuated its effects on the 5-HT output
(saline 1 apomorphine, 125 ^ 7% (n  7) versus SCH
23390 1 apomorphine 101 ^ 7% (n  7), p , 0.04, Stu-
dent's t-test) (Fig. 2). The pretreatment with SCH 23390 and
raclopride abolished the apomorphine-induced stereotypies.
Interaction with 5-HT1A autoreceptors
The effect of drugs that increase the synaptic availability of
5-HT in the DR is limited by a negative feedback
mechanism involving raphe 5-HT1A autoreceptors (Artigas
et al. 1996). We therefore examined whether 5-HT1A
receptors restrained the apomorphine-induced increase in
5-HT output. The administration of the selective 5-HT1A
receptor antagonist WAY 100635 (0.3 mg/kg s.c.) markedly
enhanced the 5-HT output in the DR with respect to control
rats injected with saline (F1,9  4.79, p , 0.06 dose effect;
F15,135  5.03, p , 0.00001 time effect; F15,135  5.75,
p , 0.00001 time±dose interaction; Fig. 1e). The 5-HT
output rose to 300% of baseline and declined slowly
thereafter. In contrast, WAY 100635 (0.3 mg/kg s.c.) did
not signi®cantly alter the 5-HT output in striatum (Fig. 1f ).
The administration of WAY 100635 0.3 mg/kg s.c. in
combination with apomorphine 3 mg/kg s.c. increased the
5-HT output signi®cantly more than apomorphine alone
(F15,135  8.12, p , 0.00001 time effect; F15,135  5.99,
p , 0.00001 time±treatment interaction; Fig. 1e). This
effect was not merely additive, since the combined treatment
elevated the 5-HT output to < 550% of baseline. In dorsal
striatum, the treatment with WAY 100635 0.3 mg/kg s.c.
and apomorphine 3 mg/kg s.c. increased the 5-HT output
comparably to apomorphine alone (Fig. 1f).
Effects of the local application of apomorphine and
quinpirole in the DR
In rats implanted with two probes, the perfusion of
apomorphine in the DR (10, 100 and 300 mm, four fractions
each) reduced the 5-HT output at the higher concentration
used (F15,150  2.6, p , 0.002 time effect; F15,150  1.58,
p  0.083 time±treatment interaction Fig. 3a). Apomor-
phine infusion in the DR did not signi®cantly alter the 5-HT
output in dorsal striatum (Fig. 3b). The perfusion of
quinpirole (10, 100 and 300 mm, four fractions each;
n  10) in the DR did not affect signi®cantly the 5-HT
output in either region (Figs 3c and d).
In a previous report, the infusion of apomorphine
(10±100 mm) induced a transient increase of the 5-HT
output in the DR (FerreÂ and Artigas 1993). To examine the
reasons of this discrepancy, we conducted two additional
experiments in which apomorphine (100 mm) was infused in
the DR using two slightly different positions of the probes,
i.e. aimed at the centre of the DR and in a slightly more
lateral coordinate, to sample the lateral wings of the DR, as
described in FerreÂ et al. (1994). Apomorphine infusion did
Fig. 5 Cellular localization of 5-HT transporter mRNA (a and c) and
dopamine D2 receptor (b and d) mRNA in the rat dorsal raphe
nucleus (DR). Pictures are dark-®eld photomicrographs of emulsion-
dipped consecutive sections. Note that the hybridization intensity
with the dopamine D2 receptor labelled probe as well as the number
of D2 receptor mRNA positive cells (b and d) is much lower than the
one observed for the 5-HT transporter probe (a and c) in the DR,
indicating a lower abundance of the DA D2 receptor mRNA in this
brain area. This is not the case in the substantia nigra pars com-
pacta (e), where dopaminergic cells are highly enriched with the
mRNA coding for the DA D2 receptor. Arrows point to some of the
few cells apparently expressing both transcripts in the DR (sections
A-C and B-D are adjacent). (Bars  a, b and e 250 mm; c, d
200 mm.)
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not signi®cantly increase the 5-HT output in either location
(n  4 rats/group; data not shown).
Single unit recordings: effects of the administration of
dopaminergic agents on serotonergic cell ®ring
The administration of saline did not affect the ®ring rate of
DR 5-HT neurons. The non-selective DA receptor agonist
apomorphine (50±400 mg/kg i.v.) increased the ®ring rate in
six out of the nine neurons tested. There was little difference
between the effects of low and high doses of apomorphine
(Fig. 4a). Paired Student's t-test revealed a signi®cant
difference between the baseline ®ring rate and that after
the administration of 100 mg/kg ( p , 0.008, n  5) or
200 mg/kg ( p , 0.001, n  6). Irrespectively of the dose at
which maximal effect was attained, this was signi®cantly
different from baseline ( p , 0.002, n  6). Two other
neurons were inhibited and one remained unaffected by the
i.v. administration of apomorphine. When considering all
5-HT neurons, the effect was marginally signi®cant
( p  0.10). The further treatment with the selective
5-HT1A receptor agonist 8-OH-DPAT (0.5±6 mg/kg) sup-
pressed the ®ring activity in all units tested. The DA D2
receptor antagonist raclopride (125 mg/kg i.v.) slightly
(2 19%) reduced the ®ring rate of DR 5-HT neurons,
although this change was not signi®cant and, injected 4 min
before, prevented the increase in ®ring rate induced by
cumulative doses of apomorphine (100±600 mg/kg i.v.;
n  4) (Fig. 4b). Likewise, the DA D1 receptor antagonist
SCH 23390 (400 mg/kg i.v) non-signi®cantly reduced
serotonergic ®ring rate (2 20%) and, injected 4 min before,
it also antagonized the increase in cell ®ring elicited by the
injection of apomorphine (100±400 mg/kg i.v.; n  4;
Fig. 4b).
The i.v. administration of the DA D2-like agonist
quinpirole also enhanced the ®ring rate of 5-HT neurons
of the DR, although this effect was somewhat less marked
than that of apomorphine (Figs 4c and d). At 80 mg/kg,
quinpirole signi®cantly increased the ®ring rate of 5-HT
cells compared to baseline ( p , 0.025, n  5) whereas at
a higher dose (160 mg/kg) the effect was marginally
signi®cant ( p  0.095, n  6).
Micropressure injection of Dulbecco's solution (used as
vehicle) did not alter the ®ring rate of 5-HT neurons. We
used veratridine as a positive control to depolarize 5-HT
neurons. The injection of veratridine (0.4±3.2 pmol)
increased the ®ring rate of all 5-HT neurons tested (n  5;
maximal effect 1277% at 0.8 pmol in one neuron; data not
shown). The administration of quinpirole by micropressure
injection affected 5-HT neurons in a bimodal manner. In
16 cells of seven different rats, quinpirole (0.2±8 pmol)
markedly inhibited the serotonergic ®ring rate (Fig. 4e). The
mean inhibition was 53% (maximal 85% at 8 pmol injected;
average of four rats). However, in ®ve neurons of the same
rats, the application of quinpirole was without effect up to
6 pmol (Fig. 4f). Neither neuron was excited by the
application of quinpirole. Both quinpirole-sensitive and
-insensitive 5-HT neurons were found randomly in descents
along the midline. At the end of the experiments in each rat,
we administered 8-OH-DPAT to con®rm the serotonergic
nature of the last neuron recorded.
Fig. 6 Cellular localization of GAD mRNA (a) and dopamine D2
receptor mRNA (b) in the periaqueductal grey matter (PAG).
Pictures are dark-®eld photomicrographs of emulsion-dipped sec-
tions. Box in (c) (modi®ed from Paxinos and Watson atlas; CD-ROM
edition) illustrates the anatomical level. Observe the relative
abundance of GAD positive cells (arrowheads) with a high hybridiz-
ation labelling in PAG (a) and the existence of D2 receptor positive
cells (arrowheads) in this same area (b) with lower levels of expres-
sion and abundance. Note that unlike in the previous ®gure, sections
shown in (a) and (b) were not consecutive. (Bar  100 mM.)
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In situ hybridization studies
Rat brain coronal sections at different anterior±posterior
levels of the DR were treated as described (see Methods)
and hybridized with probes complementary to the mRNA
encoding the DA D2 receptor. 5-HT cells in adjacent
sections were labelled with a 35S-oligonucleotide probe
directed against the 5-HT transporter. Figure 5 shows in situ
hybridization autoradiograms of the DR at two different
magni®cations (Figs 5a±b, c±d). A large number of 5-HT
neurons were labelled by the oligonucleotide probe directed
against the 5-HT transporter (Figs 5a and c). However, very
few cells showed the presence of the DA D2 transcript
(Figs 5b and d). The substantia nigra pars compacta showed
abundant dopaminergic neurons that were labelled by the
same oligonucleotide probe (Fig. 5e). In the DR, very
few neurons (marked by arrows) appeared to be labelled
by both oligonucleotide probes in adjacent sections (Figs
5a±d).
In the PAG adjacent to the DR there was an abundance of
cells containing the transcript for the DA D2 receptor
(Fig. 6a). This area was also very rich in GABAergic
neurons, as labelled by the transcript for GAD, the GABA-
synthesizing enzyme (Fig. 6b) (unlike in the previous ®gure,
these sections are not adjacent).
Dual probe experiments in SN and DR
The missmatch between the local and systemic effects of
apomorphine and quinpirole suggested that the dopamin-
ergic receptors responsible for the systemic effect of these
drugs were not located in the DR. Given the presence of a
large density of DA D2 receptors in the SN and the existence
of anatomical and functional relationships between the SN
and the DR (see Introduction) we performed dual probe
experiments to examine whether dopaminergic receptors in
the SN could be involved in the effects of systemic
apomorphine administration. Control rats perfused with
arti®cial CSF for the whole experiments did not show any
change in the 5-HT output in either region. The infusion of
TTX (10 mm) in the SN markedly reduced the 5-HT release
in this structure compared to controls (F9,90  8.24
p , 0.00001 time effect; F9,90  8.56 p , 0.00001 time±
treatment interaction) and evoked a parallel increase in the
DR (F9,63  3.14, p , 0.005, time±treatment interaction)
(Figs 7a and b). Likewise, the application of apomorphine
(10±100 mm) in the SN signi®cantly enhanced the 5-HT in
the DR compared with controls (F9,72  2.88, p , 0.005,
time±treatment interaction; Fig. 8). In this case, the 5-HT
concentration in samples of SN during the application of
apomorphine could not be determined due to the presence of
interfering peaks in the HPLC trace.
Discussion
The present study examined the effects of dopaminergic
agents on the activity of DR 5-HT neurons using two
Fig. 7 Dual probe experiments in the SN and DR. The application
of 10 mM TTX (X) in the SN (a) reduced markedly the 5-HT output in
this area and increased it in the DR (b). Data are mean ^SE of ®ve
rats. Controls (W, n  4) were perfused with arti®cial CSF. See
Results for statistical details.
Fig. 8 In dual probe experiments, the application of 100 mM apo-
morphine (X) in the SN signi®cantly raised the 5-HT output in the
DR. The 5-HT content in samples from SN could not be determined
due to interfering peaks in the HPLC trace (likely apomorphine impu-
rities). Data are mean ^SE of six rats. Controls (W, n  4) were
perfused with arti®cial CSF. See Results for statistical details.
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different techniques, in vivo microdialysis in freely moving
rats and single unit recordings in the DR of anaesthetized
rats. Overall, the results support a facilitatory action of DA
D1 and D2 receptors on the activity of DR 5-HT neurons and
of the 5-HT release in the DR. However, the single
activation of DA D2 receptors is not suf®cient to increase
the striatal 5-HT release.
In agreement with previous data (FerreÂ et al. 1994), the
systemic administration of apomorphine enhanced the 5-HT
output in the DR at all doses examined. This effect appears
to involve DA D1 and D2 receptors, since it was fully
antagonized by SCH 23390 and partly by raclopride. The
involvement of DA D2 receptors in the control of DR 5-HT
output is also supported by the increase produced by
quinpirole. The fact that SCH 23390 reduced 5-HT levels to
below baseline may be indicative of a tonic control of 5-HT
release in the DR by DA D1 receptors.
Also, as previously observed at 0.5 mg/kg (Mendlin et al.
1998), apomorphine increased the 5-HT output in the dorsal
striatum at this and higher doses. The antagonism of this
effect by SCH 23390 supports the involvement of DA D1
receptors. However, Mendlin et al. (1998) reported that
systemic raclopride antagonized the increase in striatal 5-HT
output produced by apomorphine, an observation that
appears to be at variance with the unchanged striatal 5-HT
output after quinpirole administration observed in the
present study. A higher quinpirole dose (1 mg/kg s.c.) was
also without effect in striatum and increased the 5-HT
output in the DR (MartõÂn-Ruiz and Artigas, unpublished
observations). Moreover, the local application of 10 mm
(FerreÂ et al. 1994) or higher (up to 1 mm) quinpirole
concentrations (AbellaÂn et al. 2000b) in dorsal striatum did
not change the local 5-HT output. These observations raise
doubts about the role of DA D2 receptors in the control of
the striatal 5-HT output. Thus, the present microdialysis
experiments suggest that both DA D1 and D2 receptors are
involved in the stimulatory effect of apomorphine on the
5-HT output in the DR but only the former appear to control
the striatal 5-HT output.
In addition to increasing DR 5-HT output, apomorphine
and quinpirole enhanced the ®ring rate of DR 5-HT neurons.
Data from in vivo microdialysis and single unit recordings
are not directly comparable due to the different routes of
drug administration, the use of anaesthetized rats in single
unit experiments and the distinct time scale of both
techniques. However, the 5-HT release in the DR is
sensitive to the propagation of nerve impulses, as it is
reduced by TTX and 5-HT1A agonists (Matos et al. 1996;
Casanovas et al. 1997) and increased by depolarizing agents
such as KCl or veratridine (Casanovas et al. unpublished
observations). Thus, it is conceivable that the increase in DR
5-HT output produced by apomorphine results from a higher
discharge rate of 5-HT neurons observed in single unit
experiments. In agreement, Fornal et al. (1996a) observed an
increase in serotonergic ®ring rate after the administration of
apomorphine to awake cats.
The change in 5-HT cell ®ring elicited by dopaminergic
agents was moderate (^ 20±35%). This hindered the
®nding of a clear dose-effect relationship, as the effects of
the lower doses employed were nearly maximal. SCH 23390
and raclopride signi®cantly antagonized the enhancing
effect of apomorphine. Thus, the facilitation of serotonergic
activity by apomorphine appears to involve DA D1 and D2
receptors, as also observed in microdialysis experiments
performed in the DR (see above). DA D2 (but not DA D1)
receptors are present in a moderate density in the DR
(Bouthenet et al. 1987; Palacios and Pazos 1987). This
raised the possibility that they mediate the facilitatory
effects of apomorphine and quinpirole on 5-HT neurons.
However, the local application of these dopaminergic
agonists in the DR in a wide range of concentrations did
not increase the 5-HT output in this area or dorsal striatum
in dual probe experiments. This is in contrast with previous
observations from this laboratory showing that the appli-
cation of apomorphine and quinpirole in the DR induced a
moderate and transient increase in the local 5-HT output
(FerreÂ and Artigas 1993). This discrepancy does not appear
to be accountable by methodological factors such as probe
type and location, perfusion ¯uid, analytical method, etc.
Similar procedures were used in past and present studies,
with the exception that the rats used herein were gently
manipulated before experiments to reduce the effects of the
stress/arousal associated to handling and injection on the
raphe 5-HT output (Adell et al. 1997). In the present study,
this increase was only evident in rats injected twice (e.g.
antagonist experiments). It is thus possible that a distinct
behavioural state of rats may play a role in this discrepancy.
Interestingly, Mendlin et al. (1999) noted that raclopride
attenuated the striatal 5-HT increase induced by behavioural
activation but did not alter the basal 5-HT output in this
area, as previously observed (FerreÂ et al. 1994). On the other
hand, the blockade of postsynaptic 5-HT receptors attenu-
ated the increase of the DA output in activated but not basal
conditions (de DeurwaerdeÁre and Spampinato 1999). These
observations suggest a complex interaction between DA and
5-HT systems in which phasic stimuli may play an
important role.
The dorsal striatum is exclusively innervated by 5-HT
neurons from the DR (Azmitia and Segal 1978). 5-HT1A
receptor antagonists augment the effects of drugs that
increase extracellular 5-HT in the DR by preventing a
negative feedback mediated by 5-HT1A autoreceptors
(Artigas et al. 1996). The WAY 100635-induced poten-
tiation of the effect of apomorphine on the DR 5-HT output
suggests that 5-HT1A autoreceptors also limit the effect
of apomorphine on the DR output. This agrees in part
with the conclusion from previous experiments showing
that the 5-HT1A receptor antagonist WAY 100135 reversed
Dorsal raphe neurons and DA D2 receptors 771
q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 77, 762±775
a moderate inhibition in striatal 5-HT output produced by
apomorphine (FerreÂ et al. 1994). Although the net effect
of apomorphine on striatal 5-HT output differed markedly
in both studies, the fact that apomorphine 1 5-HT1A
antagonist combinations elevated 5-HT more than apomor-
phine alone in one or other area supports the notion that
apomorphine indirectly increases the tone on 5-HT1A
autoreceptors.
The increase in DR 5-HT output elicited by WAY 100635
alone is consistent with the increase in serotonergic ®ring
rate elicited by this agent in awake cats (Fornal et al. 1996b)
and in midbrain slices containing the DR (Corradetti et al.
1996) although no such effect was observed in anaesthetized
rats (Gartside et al. 1995). WAY 100635 might antagonize a
tonic self-inhibition of the activity of 5-HT neurons, this
leading to an increased release in the DR. However, we
cannot discard that WAY 100635 reversed a citalopram-
induced inhibition of 5-HT release in the DR given the
presence of the SSRI in the perfusion ¯uid. WAY 100635
administration markedly potentiated the increase in 5-HT
output produced by a larger (50 mm) citalopram concen-
tration that activates raphe 5-HT1A autoreceptors (Romero
and Artigas 1997). Yet, it is unclear whether 1 mm
citalopram, which elicits a partial blockade of the 5-HT
reuptake (in vivo EC50  1.0 mm; HervaÂs et al. 2000) can
activate suf®ciently 5-HT1A autoreceptors as to attenuate the
local 5-HT release. Contrary to the DR, WAY 100635 did
not elevate the striatal 5-HT output when given alone, as
previously observed (Romero and Artigas 1997), nor did it
potentiate the effect of apomorphine in striatum (Mendlin
et al. 1998; this study) which suggests a distinct sensitivity
of the 5-HT release in both areas to WAY 100635
administration.
Quinpirole excited 5-HT neurons when administered
systemically but not when applied in the DR. On the
contrary, micropressure injection of quinpirole inhibited
more than 70% of the neurons tested. Vehicle applications
were without effect and veratridine dramatically increased
the ®ring rate of 5-HT neurons, which validates the
technique used. The local effect of quinpirole would be
consistent with the inhibitory responses elicited by DA D2
receptor stimulation (Vallar and Meldolesi 1991). However,
few serotonergic neurons expressed this receptor subtype in
the DR, which precludes their involvement in the local
effects of quinpirole. Recently, dopamine was found to
depolarize 5-HT neurons in vitro by an action on DA D2
receptors (Haj-Dahmane and Shen 2000) which further
complicates the understanding of the DA25-HT interaction
in the DR. It is unlikely that quinpirole-sensitive neurons
were dopaminergic because of their ®ring characteristics,
response to 8-OH-DPAT (when assessed) and low number
in the DR (HoÈkfelt et al. 1976; Geffard et al. 1987; KaleÂn
et al. 1988). Moreover, all recorded neurons were found in
descents along the midline, containing dopaminergic ®bres
but few DA cell bodies (Geffard et al. 1987). It is possible
that the inhibition of 5-HT neurons by quinpirole results
from a non-speci®c effect at the local doses used. Quinpirole
and 8-OH-DPAT display common behavioural actions
(Ahlenius and Larsson 1997). Yet, despite the high density
of 5-HT1A receptors in the DR and its inhibitory role, it is
unlikely that quinpirole inhibits 5-HT neurons by activation
of 5-HT1A autoreceptors since quinpirole displays low
af®nity for 5-HT1A receptors (Toll et al. 1998) and
these are present in all 5-HT DR neurons (Sotelo et al.
1990) whereas quinpirole only inhibited 16 of the 21
neurons tested.
The scarcity of 5-HT neurons containing the DA D2
receptor transcript and the fact that systemic quinpirole and
apomorphine increased 5-HT cell ®ring and release suggests
that the facilitation of serotonergic transmission produced by
these agents is indirect, possibly through dopaminergic
receptors in areas projecting to the DR. Several such areas
exist in the midbrain that exhibit a moderate or high density
of DA D2 receptors, such as the SN, the ventral tegmental
area and the lateral habenula (Bouthenet et al. 1987;
Palacios and Pazos 1987). In addition, the PAG, in close
vicinity to the DR, contains dense plexuses of dopaminergic
®bres (Peyron et al. 1995) and a large density of DA D2
receptors (Bouthenet et al. 1987) as well as GABAergic
afferents to the DR (Gervasoni et al. 2000).
The activity of DR 5-HT neurons is tonically inhibited by
GABA during periods of low behavioural activity, such as
the light period in rats ± present experimental conditions ±
(Nitz and Siegel 1997; Gervasoni et al. 2000). The
activation of inhibitory receptors such as m-opioid or
GABAB located on these GABAergic afferents disinhibits
5-HT neurons and increases the 5-HT release in the DR (Tao
and Auerbach 1994; Jolas and Aghajanian 1997; AbellaÂn
et al. 2000a). The presence of GAD and DA D2 transcripts
in the PAG suggests that such a mechanism might
participate in the increase in cell ®ring and 5-HT release
elicited by apomorphine and quinpirole. It remains to be
established (e.g. by using double in situ hybridization)
whether both transcripts colocalize. Also, further work is
needed to examine this possibility at a functional level using
techniques other than dual probe microdialysis due to the
proximity of the PAG and the DR.
In addition, DA receptors in the SN could be involved in
the facilitatory effects of apomorphine and quinpirole on
5-HT neurons. The electrical stimulation of the SN
suppressed the ®ring activity of DR 5-HT neurons (Stern
et al. 1981) and somatodendritic DA receptors in the SN
were postulated to regulate the activity of the raphe-striatal
pathway (HeÂry et al. 1980). The dual-probe experiments
conducted in the present study support the notion that the
dopaminergic receptors in the SN may be involved in
the effects of apomorphine on DR 5-HT neurons. Thus, the
suppression of nerve impulses in the SN by TTX increased
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the 5-HT output in the DR, which supports an inhibitory role
of the SN on DR activity in accordance with previous
electrophysiological evidence (Stern et al. 1981). Since the
5-HT output in the DR is markedly reduced by the local
application of TTX (Matos et al. 1996) it is obvious that
TTX diffusion to the DR cannot account for the 5-HT
increase observed. The limited spatial resolution of dialysis
probes (1.5-mm tip size) does not enable to conclude which
part of the SN was involved in this effect but, conceivably,
TTX suppressed the nigral GABAergic output to the
midbrain (Chevalier and Deniau 1990), thus disinhibiting
5-HT neurons.
Furthermore, the activation of DA receptors in the SN by
apomorphine enhanced the 5-HT output in the DR. Given
the greater increase in DR output produced by apomorphine
(versus quinpirole) we preferred to use the former, despite
its lack of selectivity for DA D1 and D2 receptors. Indeed,
the maximal effect size in the DR was moderate (,25%).
However, apomorphine was applied unilaterally, thus affect-
ing half of the nigral neurons putatively affected by systemic
administration. These results are in agreement with the
observation that the application of l-DOPA by reverse
dialysis in the SN of freely moving rats increased the local
5-HT output and that in striatum (ThorreÂ et al. 1998) which
also appears to support a facilitatory action of nigral DA on
the activity of the raphe-striatal pathway. Given the non-
selective actions of apomorphine and the presence of DA D1
receptors in the SN (Levey et al. 1993) both receptor
subtypes might be involved in apomorphine effects.
In summary, the present results provide further evidence
of a complex control of the serotonergic activity by
dopaminergic transmission. Both DA D2 and D1 receptors
are involved in the control of serotonergic activity and 5-HT
release in the DR, whereas only the latter appear to mediate
the facilitatory effects of apomorphine in the dorsal striatum.
Based on the mismatch between the effects of local and
systemic applications of drugs (also supported by mRNA
data) we propose that dopaminergic receptors outside the
DR control the activity of serotonergic neurons. A sub-
population of these receptors appears to be located in the
SN, although other brain areas cannot be discarded and in
particular the PAG, rich in DA D2 receptor and GAD
transcripts.
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